Gusev E, Zhuravleva Y (2022) Inflammation: a New look at an old problem. Int J Mol Sci 23:4596

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akter S, Sharma RK, Sharma S, Rastogi S, Fiebich BL, Akundi RS (2021) Exogenous ATP modulates PGE2 release in macrophages through sustained phosphorylation of CDK9 and p38 MAPK. J Leukoc Biol 110:663–677

Article  CAS  PubMed  Google Scholar 

Akundi RS, Candelario-Jalil E, Hess S, Hull M, Lieb K, Gebicke-Haerter PJ, Fiebich BL (2005) Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia 51:199–208

Article  PubMed  Google Scholar 

Ferrandina G, Lauriola L, Zannoni GF, Fagotti A, Fanfani F, Legge F, Maggiano N, Gessi M, Mancuso S, Ranelletti FO, Scambia G (2002) Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. Ann Oncol 13:1205–1211

Article  CAS  PubMed  Google Scholar 

Bocca C, Ievolella M, Autelli R, Motta M, Mosso L, Torchio B, Bozzo F, Cannito S, Paternostro C, Colombatto S, Parola M, Miglietta A (2014) Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness. Expert Opin Ther Targets 18:121–135

Article  CAS  PubMed  Google Scholar 

Zhang H, Sun XF (2002) Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol 97:1037–1041

Article  CAS  PubMed  Google Scholar 

Hill R, Li Y, Tran LM, Dry S, Calvopina JH, Garcia A, Kim C, Wang Y, Donahue TR, Herschman HR, Wu H (2012) Cell intrinsic role of COX-2 in pancreatic cancer development. Mol Cancer Ther 11:2127–2137

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cetin M, Buyukberber S, Demir M, Sari I, Sari I, Deniz K, Eser B, Altuntas F, Camci C, Ozturk A, Turgut B, Vural O, Unal A (2005) Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival. Am J Hematol 80:169–173

Article  CAS  PubMed  Google Scholar 

Sharma S, Kalra H, Akundi RS (2020) Extracellular ATP mediates Cancer Cell Migration and Invasion through increased expression of cyclooxygenase 2. Front Pharmacol 11:617211

Article  CAS  PubMed  Google Scholar 

Han Y, Guo W, Ren T, Huang Y, Wang S, Liu K, Zheng B, Yang K, Zhang H, Liang X (2019) Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis. Cancer Lett 440–441:116–125

Article  PubMed  Google Scholar 

Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ (2015) Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study. Clin Cancer Res 21:756–762

Article  CAS  PubMed  Google Scholar 

Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M (2004) Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364:2021–2029

Article  CAS  PubMed  Google Scholar 

Ozleyen A, Yilmaz YB, Donmez S, Atalay HN, Antika G, Tumer TB (2023) Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention. J Cancer Res Clin Oncol 149:2095–2113

Article  CAS  PubMed  Google Scholar 

Fiebich BL, Akter S, Akundi RS (2014) The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain. Front Cell Neurosci 8:260

Article  PubMed  PubMed Central  Google Scholar 

Lecciso M, Ocadlikova D, Sangaletti S, Trabanelli S, De Marchi E, Orioli E, Pegoraro A, Portararo P, Jandus C, Bontadini A, Redavid A, Salvestrini V, Romero P, Colombo MP, Di Virgilio F, Cavo M, Adinolfi E, Curti A (2017) ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T Cells and tolerogenic dendritic cells. Front Immunol 8:1918

Article  PubMed  PubMed Central  Google Scholar 

Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18:601–618

Article  PubMed  Google Scholar 

Ma X, Pan X, Wei Y, Tan B, Yang L, Ren H, Qian M, Du B (2016) Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activation. Oncotarget 7:29036–29050

Article  PubMed  PubMed Central  Google Scholar 

Vultaggio-Poma V, Sarti AC, Di Virgilio F (2020) Extracellular ATP: a feasible target for Cancer Therapy. Cells 9:2496

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gandhapudi SK, Ward M, Bush JPC, Bedu-Addo F, Conn G, Woodward JG (2019) Antigen priming with enantiospecific cationic lipid nanoparticles induces potent Antitumor CTL responses through Novel induction of a type I IFN response. J Immunol 202:3524–3536

Article  CAS  PubMed  Google Scholar 

Di Rosso ME, Sterle HA, Cremaschi GA, Genaro AM (2018) Beneficial effect of fluoxetine and sertraline on chronic stress-induced tumor growth and cell dissemination in a mouse model of ymphoma: crucial role of antitumor immunity. Front Immunol 9:1341

Article  PubMed  PubMed Central  Google Scholar 

Agnihotri SK, Sun L, Yee BK, Shen R, Akundi RS, Zhi L, Duncan MJ, Cass WA, Bueler H (2019) PINK1 deficiency is associated with increased deficits of adult hippocampal neurogenesis and lowers the threshold for stress-induced depression in mice. Behav Brain Res 363:161–172

Article  CAS  PubMed  Google Scholar 

Jacobson KA, Delicado EG, Gachet C, Kennedy C, von Kugelgen I, Li B, Miras-Portugal MT, Novak I, Schoneberg T, Perez-Sen R, Thor D, Wu B, Yang Z, Muller CE (2020) Update of P2Y receptor pharmacology: IUPHAR Review 27. Br J Pharmacol 177:2413–2433

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shchors K, Massaras A, Hanahan D (2015) Dual targeting of the autophagic regulatory circuitry in gliomas with repurposed drugs elicits cell-lethal autophagy and therapeutic benefit. Cancer Cell 28:456–471

Article  CAS  PubMed  Google Scholar 

Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15:117–134

Article  PubMed  PubMed Central  Google Scholar 

Na TY, Schecterson L, Mendonsa AM, Gumbiner BM (2020) The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci U S A 117:5931–5937

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cruz-Munoz W, Sanchez OH, Di Grappa M, English JL, Hill RP, Khokha R (2006) Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3-/- mice. Oncogene 25:6489–6496

Article  CAS  PubMed  Google Scholar 

Bhargava S, Hotz B, Hines OJ, Reber HA, Buhr HJ, Hotz HG (2007) Suramin inhibits not only tumor growth and metastasis but also angiogenesis in experimental pancreatic cancer. J Gastrointest Surg 11:171–178

Article  PubMed  Google Scholar 

Small EJ, Halabi S, Ratain MJ, Rosner G, Stadler W, Palchak D, Marshall E, Rago R, Hars V, Wilding G, Petrylak D, Vogelzang NJ (2002) Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480. J Clin Oncol 20:3369–3375

Article  CAS  PubMed  Google Scholar 

Wiedemar N, Hauser DA, Maser P (2020) 100 years of Suramin. Antimicrob Agents Chemother 64:10–1128

Article  Google Scholar 

Illes P, Muller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178:489–514